Platelet-rich plasma versus autologous blood versus steroid injection in lateral epicondylitis: systematic review and network meta-analysis
- PMID: 26362783
- PMCID: PMC4882297
- DOI: 10.1007/s10195-015-0376-5
Platelet-rich plasma versus autologous blood versus steroid injection in lateral epicondylitis: systematic review and network meta-analysis
Abstract
Background: Clinical outcomes between the use of platelet-rich plasma (PRP), autologous blood (AB) and corticosteroid (CS) injection in lateral epicondylitis are still controversial.
Materials and methods: A systematic review and network meta-analysis of randomized controlled trials was conducted with the aim of comparing relevant clinical outcomes between the use of PRP, AB and CS injection. Medline and Scopus databases were searched from inception to January 2015. A network meta-analysis was performed by applying weight regression for continuous outcomes and a mixed-effect Poisson regression for dichotomous outcomes.
Results: Ten of 374 identified studies were eligible. When compared to CS, AB injection showed significantly improved effects with unstandardized mean differences (UMD) in pain visual analog scale (VAS), Disabilities of Arm Shoulder and Hand (DASH), Patient-Related Tennis Elbow Evaluation (PRTEE) score and pressure pain threshold (PPT) of -2.5 (95 % confidence interval, -3.5, -1.5), -25.5 (-33.8, -17.2), -5.3 (-9.1, -1.6) and 9.9 (5.6, 14.2), respectively. PRP injections also showed significantly improved VAS and DASH scores when compared with CS. PRP showed significantly better VAS with UMD when compared to AB injection. AB injection has a higher risk of adverse effects, with a relative risk of 1.78 (1.00, 3.17), when compared to CS. The network meta-analysis suggested no statistically significant difference in multiple active treatment comparisons of VAS, DASH and PRTEE when comparing PRP and AB injections. However, AB injection had improved DASH score and PPT when compared with PRP injection. In terms of adverse effects, AB injection had a higher risk than PRP injection.
Conclusions: This network meta-analysis provided additional information that PRP injection can improve pain and lower the risk of complications, whereas AB injection can improve pain, disabilities scores and pressure pain threshold but has a higher risk of complications.
Level of evidence: Level I evidence.
Keywords: Autologous blood; Corticosteroid; Lateral epicondylitis; Network meta-analysis; PRP; Systematic review.
Figures
Similar articles
-
Platelet-Rich Plasma Vs Autologous Blood Vs Corticosteroid Injections in the Treatment of Lateral Epicondylitis: A Systematic Review, Pairwise and Network Meta-Analysis of Randomized Controlled Trials.PM R. 2020 Apr;12(4):397-409. doi: 10.1002/pmrj.12287. Epub 2020 Jan 13. PM R. 2020. PMID: 31736257 Free PMC article.
-
Corticosteroid injections for the treatment of lateral epicondylitis are superior to platelet-rich plasma at 1 month but platelet-rich plasma is more effective at 6 months: an updated systematic review and meta-analysis of level 1 and 2 studies.J Shoulder Elbow Surg. 2023 Sep;32(9):1770-1783. doi: 10.1016/j.jse.2023.04.018. Epub 2023 May 27. J Shoulder Elbow Surg. 2023. PMID: 37247780
-
Autologous blood and platelet-rich plasma injection therapy for lateral elbow pain.Cochrane Database Syst Rev. 2021 Sep 30;9(9):CD010951. doi: 10.1002/14651858.CD010951.pub2. Cochrane Database Syst Rev. 2021. PMID: 34590307 Free PMC article.
-
Use of Adjunctive Platelet-Rich Plasma for Healing During Arthroscopic Release and Repair for Recalcitrant Lateral Epicondylitis: A Prospective, Double-Blind, Randomized Controlled Trial.Am J Sports Med. 2025 Jul;53(8):1817-1825. doi: 10.1177/03635465251341458. Epub 2025 May 31. Am J Sports Med. 2025. PMID: 40448507 Clinical Trial.
-
A systematic review on the efficacy of different types of platelet-rich plasma in the management of lateral epicondylitis.J Shoulder Elbow Surg. 2022 Jul;31(7):1533-1544. doi: 10.1016/j.jse.2022.02.017. Epub 2022 Mar 23. J Shoulder Elbow Surg. 2022. PMID: 35337955
Cited by
-
Platelet-Rich Plasma Injections as an Alternative to Surgery in Treating Patients With Medial Epicondylitis: A Systematic Review.Cureus. 2022 Aug 25;14(8):e28378. doi: 10.7759/cureus.28378. eCollection 2022 Aug. Cureus. 2022. PMID: 36171858 Free PMC article. Review.
-
The effects of regenerative injection therapy compared to corticosteroids for the treatment of lateral Epicondylitis: a systematic review and meta-analysis.Arch Physiother. 2019 Nov 13;9:12. doi: 10.1186/s40945-019-0063-6. eCollection 2019. Arch Physiother. 2019. PMID: 31754461 Free PMC article. Review.
-
Comparison of the Clinical Results of Platelet-Rich Plasma, Steroid and Autologous Blood Injections in the Treatment of Chronic Lateral Epicondylitis.Healthcare (Basel). 2023 Mar 6;11(5):767. doi: 10.3390/healthcare11050767. Healthcare (Basel). 2023. PMID: 36900772 Free PMC article.
-
[Treatment of lateral and medial epicondylopathy : Are platelet-rich plasma, shock wave therapy, etc. effective for both?].Orthopadie (Heidelb). 2023 May;52(5):371-378. doi: 10.1007/s00132-023-04372-8. Epub 2023 Apr 13. Orthopadie (Heidelb). 2023. PMID: 37052648 Review. German.
-
A comparative study to evaluate the efficacy of platelet-rich plasma and triamcinolone to treat tennis elbow.Indian J Orthop. 2017 May-Jun;51(3):304-311. doi: 10.4103/ortho.IJOrtho_181_16. Indian J Orthop. 2017. PMID: 28566783 Free PMC article.
References
-
- Creaney L, Wallace A, Curtis M, Connell D. Growth factor-based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single-blind, randomised trial of autologous blood injections versus platelet-rich plasma injections. Br J Sports Med. 2011;45(12):966–971. doi: 10.1136/bjsm.2010.082503. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials